I move: "That the Bill be now read a Second Time."
I am pleased to address the House today on the Second Stage of the Health Insurance (Amendment) Bill 2003. This is a brief Bill aimed at facilitating the early submission of a draft risk equalisation scheme for affirmation by the House, as provided for under the Health Insurance Acts 1994 and 2001. The need for the further provisions set out in the Bill arises from comprehensive consultations held with the Health Insurance Authority since its establishment and matters that arose in the course of preparing the detailed risk equalisation scheme. The authority will have a key role in the determination of whether risk equalisation is commenced, and also in the monitoring and the administration of the scheme.
The Bill has two main provisions. The first provides a broad immunity from liability for damages for the Health Insurance Authority when discharging its statutory functions in good faith and provides for indemnification. The second is to ensure that the temporary exemption from risk equalisation, which has as its objective the encouragement of competition, can be availed of only by genuine new entrants to the market.
The remaining provisions of the Bill cover procedural matters relating to proposed risk equalisation arrangements and to funding advanced for the establishment of the Health Insurance Authority.
A draft risk equalisation scheme has been prepared by my Department and is currently the subject of consideration by the EU Commission Competition Directorate General. I will refer to the position on bringing this to the House for approval a little later. The provisions of the scheme will aim to achieve a balance between safeguarding the stability of community rating and facilitating competition in the provision of health insurance. They will reflect the central role to be carried out by the Health Insurance Authority, HIA, both in relation to determining the necessity for the commencement of risk equalisation and the manner of its application.
The following are to be among the key features of the scheme as they relate to the HIA. It will evaluate statutory data returns from participating insurers concerning the nature and distribution of insured risks between those insurers. It will prepare and submit reports and recommendations to the Minister for Health and Children, on the basis of its evaluation and analysis of the returns received from insurers. The scheme provides for the HIA to have a major responsibility in relation to any decision to commence risk equalisation payments between insurers. Between two specified parameters, set out under the scheme as measures of differentials in the risk profiles of insurers, the HIA will recommend for or against the commencement of equalisation transfers between insurers. Within these parameters, it will not be open to the Minister to commence actual risk equalisation between insurers without a recommendation to that effect from the HIA. If the measure of differentials exceeds the higher parameter the Minister will be obliged to consult with the HIA as to whether there are good reasons for not commencing risk equalisation between insurers. The authority will have power to determine the basis on which risk equalisation payments should be calculated. The HIA's role in this regard will relate to the risk factors that are to be taken into account in the process. Age and gender differentials are automatically taken into account. The third factor to be included is a measure for health status, based on hospital bed utilisation. The HIA will have the power to determine the extent to which this factor is taken into account, subject to the authority having established that this is warranted by circumstances relating to the differences in risk profiles between insurers and is in the best overall interests of health insurance consumers.
The necessity for risk equalisation to support the operation of community rating in our voluntary private health insurance market going forward has been extensively discussed in the House previously. I trust that most Members will support a draft scheme that strikes a balance between maintaining community rating and facilitating competition. Under the existing legislation, a draft scheme must be submitted to each House of the Oireachtas for approval. This will remain the position on the passing of the Bill now before us for consideration.
At the general level, the objective of risk equalisation is easily appreciated. It follows logically that, in a market where the principles of community rating, open enrolment and lifetime cover apply, there must be a provision to share risk between competing health insurers. These common good principles curb the usual commercial instincts and incentives that insurers have to select good risks and avoid or discourage bad ones. In order for these principles to be sustainable, they must be supported by a balancing mechanism that enables insurers with worse than average risks to be compensated for the disproportionate level of the sick and elderly in the insured community they must cover.
From the perspective of insurers, risk equalisation addresses the competitive imbalance that can occur as a result of risk selection, whether this occurs due to deliberate actions by insurers or inadvertently because of the more mobile nature of the young and healthy and employer paid insurance. In effect risk equalisation seeks to tackle risk selection as a source of competitive advantage. This is equitable given that the usual insurance levers of underwriting and risk-based pricing are not available to competing insurers.
The consequence of risk selection is that the per capita claims cost, and consequently premiums, start to rise for those insurers who are left with a higher proportion of less healthy individuals. This is a breach of the “solidarity” principle, which is fundamental to genuine community rating. Risk equalisation addresses this by limiting the extent to which certain healthier people, by benefiting from lower premiums, and-or their insurers by taking a higher profit margin can gain at the expense of other health insurance consumers. In short, risk equalisation aims to equitably adjust differences in health insurers' costs that arise due to variations in risk profiles.
The detailed preparation of a risk equalisation scheme has been a complex matter, which has involved considerable actuarial expertise and also legal input, in addition to the consultations with the Health Insurance Authority. It has also been necessary to approach the formulation of the scheme in a manner that takes account of considerations that apply at European Union level. These relate to matters such as observance of general European Union legal principles of necessity and proportionality, competition rules and creation of the Single Market. It is widely known that plans for the regulation of our health insurance market have been the subject of fundamental differences with The British United Provident Association, BUPA, which entered the market in 1997. Given this situation and that the operation of this country's private health insurance market is subject to EU obligations, the regulatory measures to be implemented have attracted close and recurring interest on the part of EU Commission services.
My Department has, at all times, kept the Commission advised of proposed regulatory arrangements. Although the Commission has formally accepted, in principle, Ireland's entitlement to have specific legal provisions in the interest of the common good in voluntary health insurance, as allowed for under the third non-life insurance directive, it has emphasised the need for necessity and proportionality in any measures that may be taken. Furthermore, ongoing representations and complaints by BUPA have resulted in the Commission revisiting the matter on a number of occasions, up to and including the present time.
The current position is that BUPA Ireland has made a complaint to the Europe Union Commission that risk equalisation would constitute an illegal State aid and the EU's Competition Directorate General is considering a detailed notification made by my Department in response. This makes the case in relation to the necessity for risk equalisation, and furthermore that its introduction does not constitute State aid under EU competition rules. The timetable for bringing the draft scheme to the Houses of the Oireachtas will be determined in the light of the outcome of these latest deliberations at EU level. It is however my desire and intention that consideration of a draft scheme by the Houses of the Oireachtas can take place at an early date.
While the experience of EU Commission services revisiting the matter of risk equalisation on a number of occasions has impinged on the process of implementing a scheme, I would characterise recent contacts with the EU Competition Directorate General as being positive and constructive.
This is a short Bill and while some aspects are technical its provisions are relatively straightforward. Section 1 provides for interpretation. Section 2 relates to the provision of a definition of functions in the Principal Act. The authority's existing functions are addressed in sections 12, 14, 15, 17, 18 and in particular, section 21. This section clarifies that the authority's functions, inter alia, include the exercise of powers and the carrying out of duties and is thus to be construed broadly.
Section 3 arises from a request made by the Health Insurance Authority that it have protection from suit for damages corresponding to the statutory protection given to other public regulatory bodies. Accordingly, the provision gives a broad immunity to the authority itself, to individual members of the authority and to its staff where they are engaged in the discharge of their functions in good faith. It has been drafted having specific regard to a similar provision in the Irish Takeover Panel Act 1997 in respect of the takeover panel. Related provisions also apply in respect of the Commission for Electricity Regulation, while immunity from liability for damages is also provided under section 69 of the Central Bank Act 1997, section 53 of the Stock Exchange Act 1995 and section 53 of the Investment Intermediaries Act 1995.
Section 4 amends Part II of the Second Schedule to the Defamation Act 1961. As part of its functions, the authority will be required to make reports and recommendations in relation to the question of commencing financial transfers between insurers under a risk equalisation scheme. The effect of the provision is to add the authority to the bodies that have qualified privilege in respect of a copy or fair and accurate report or summary of any recommendation that the authority may produce. Qualified privilege of the same nature is contained in the Irish Takeover Panel Act 1997.
Section 5 is about refining certain procedures that will apply in the steps to be taken after a risk equalisation scheme has come into effect. The limited changes being made arise from consultations with the Health Insurance Authority. The first subsection deals with the requirement for the authority to include in its report to the Minister a recommendation on whether he ought to commence risk equalisation payments under a scheme. The legislation as it stands makes it clear that recommendations by the authority are for that purpose alone. The amendment is entirely consistent with the current position but clarifies that the authority shall not include a recommendation on the matter in a report where the Minister has already exercised the power to commence risk equalisation transfers under a scheme. The health insurance legislation already contains a provision requiring the authority to submit annual reports with respect to the operation of a scheme, once risk equalisation payments have been commenced. The legislation provides that the Minister shall cause such reports to be laid before each House. The Bill does not change this reporting requirement.
The second subsection relates to giving advance notice to parties, by either the authority or the Minister, of its proposed recommendation, in the case of the authority, or the proposed exercise of his powers to commence risk equalisation payments, in the case of the Minister. As the legislation stands, notice in such instances must issue to all registered undertakings, which are also given the opportunity to make representations. However, the legislation provides that a scheme may include a provision allowing restricted membership undertakings, such as, the occupational schemes that apply in the case of the Garda and the prison officers, to opt out of risk equalisation. It should not therefore be necessary to give notice to undertakings about proposed developments relating to the commencement of transfers under a scheme where such an option may have been used.
Section 6 is concerned with the arrangements in place to facilitate and encourage the entry of new insurers into the market to provide greater competition and choice to consumers. The legislation provides for insurance undertakings that have not yet commenced business to avail of a three year exemption from risk equalisation. The purpose of this is to allow new insurers to establish a critical mass of customers and recover start-up costs that could arise before being liable to make payments in respect of risk equalisation.
The provision in the Bill retains this measure. The main purpose of amending the existing provision is to avoid a possibility that the exemption could be availed of through the creation of a subsidiary or some other form of associated company by an existing undertaking. This approach is considered desirable to remove any possibility of an issue of avoidance arising in the arrangements. As there is no indication that an associated company of an existing undertaking was intent on, interested in or to be created for the purpose of availing of the exemption, the amendment is most appropriately regarded as a precautionary one. It aims to ensure the exemption will only apply in circumstances where the added value for consumers of private health insurance is a genuine increase in the choice of insurers and greater real competition in the market.
The section retains the three year exemption for new entrants. However, it contains provisions aimed at securing a clearer indication of the com mitment and serious business intent to actually follow through on entry to the market on the part of insurers who decide to serve a notice of exemption in the future. In that regard, it requires insurers to be registered with the Health Insurance Authority before serving a notice of exemption and to commence business not later than three months after the date of the notice. Neither of these is an onerous step and it remains in the hands of the new entrant insurer to decide the timing in relation to becoming registered and subsequently serving a notice of exemption.
Section 7 relates to financial arrangements made in relation to the Health Insurance Authority at the time of its establishment. The ongoing operational costs of the authority are funded by the proceeds of a levy on the premium income of registered insurers. The levy is currently set at a rate of 0.14% of that annual premium income. However, the legislation allowed for the Minister to advance funds to the authority and during 2001 sums amounting to more than €500,000 were advanced to the authority in respect of initial costs. As the legislation stands, the authority is obliged to repay in full the amount advanced. The authority considers that costs incurred in its establishment should be borne by the State on the grounds that it is a public body and was established to carry out a public service in relation to the common good aspects of health insurance.
This section maintains the option of the Minister effecting repayment of the €500,000 provided towards establishing the authority. It is clear that the provision is an enabling one and does not mean that part or full repayment will automatically be waived – this will be looked at strictly on its merits and will be subject to consultation with the authority.
I commend this short Bill to the House. The proposed early introduction of the risk equalisation scheme to follow enactment of the Bill will meet national requirements for sustaining the operation of the core common good principles of our voluntary private health insurance system, together with taking account of EU Commission concerns about necessity, proportionality and competition.